Ulcerative Colitis Treatment Market Size Expected to Reach USD 14.77 Bn by 2033 [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
Ottawa, May 09, 2024 (GLOBE NEWSWIRE) -- The global ulcerative colitis treatment market size was valued at USD 10.16 billion in 2023 and is predicted to hit around USD 13.81 billion by 2032, a study published by Towards Healthcare a sister firm of Precedence Research. Insight Highlights: Pancolitis, affecting the entire colon, presents the biggest challenge, holding a 34% market share in 2023. Anti-TNF biologics are the current champions, dominating the market with a 30% of medication share in 2023, but new solutions are actively sought. North America currently leads the charge, holding a 39% market share in 2023, but the global focus is increasing. Download the segmental sample of ulcerative colitis treatment market analysis in detail @ https://www.towardshealthcare.com/personalized-scope/5118 National Library of Medicine estimates that ulcerative colitis impacts between 9 and 20 individuals per 100,000 annually, with an overall prevalence of 156 to 291 cases per 100,000
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data [FOX Business Network]FOX Business Network
- Pfizer (PFE) Up 1.8% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]Yahoo! Finance
- How To Earn $500 A Month From Pfizer Stock [Yahoo! Finance]Yahoo! Finance
- Pfizer's drug for advanced lung cancer shows promising long-term trial results [CNBC]CNBC
- Pfizer drug extends life for patients with rare lung cancer usually seen in nonsmokers [MSNBC.com]MSNBC.com
PFE
Earnings
- 5/1/24 - Beat
PFE
Sec Filings
- 5/31/24 - Form SD
- 5/22/24 - Form 8-K
- 5/16/24 - Form 4
- PFE's page on the SEC website